Mission Statement

Cellular Engineering Technologies (CET) is a biotech company founded by Dr. Alan Moy with the mission to fundamentally change medicine. The drug discovery system that ultimately directs healthcare delivery has become lengthy, costly and fails to produce therapies that repair or regenerate diseased organs. The healthcare system lacks treatments for patients with orphan (rare) diseases and targeted, personalized treatments for cancer patients. CET is commercializing innovations to solve these problems by marrying tissue engineering with preferred adult stem cells. CET is developing fundamental technologies that will lead to commercial products and services to serve the personalized and regenerative medicine markets. Stem cells have the ability to renew and differentiate into specialized cells that have the potential to regenerate diseased organs and serve as research tools to discover novel medicines for previously unmet healthcare needs.